CGC stock is up 3% this morning after Canopy Growth (TSX:WEED) (NYSE:CGC) announced it had completed its acquisition of cannabis research frim Beckley Canopy Therapeutics, as well as the sale of its 13.2% stake in AusCann Group Holdings.
UK Expansion Aiding CGC Stock Recovery?Canopy Growth’s acquisition of Beckley Canopy includes the joint venture Spectrum Therapeutics and will see the two companies integrated under the Spectrum label to increase the breadth of clinical cannabis research in the UK. The company will make some changes at boardroom level for its European operations, with Paul Steckler and Steven ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.